New biosimilar approved

#Medsky🧪#pharmasky
@fda.gov approves second biosimilars to #Prolia & #Xgeva ( #denosumab) Denosumab is a type of targeted Drug #monoclonalantibody. It is for secondary bone cancer Tx . bnf.nice.org.uk/drugs/denosu...

www.accessdata.fda.gov/drugsatfda_d...